# Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer

> **NCT01614938** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 46 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Cetuximab
- **DRUG:** Cisplatin
- **DRUG:** Docetaxel
- **RADIATION:** Intensity-modulated radiotherapy
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01614938
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-08
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2012-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01614938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01614938, "Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01614938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*